{"id":63707,"date":"2024-03-29T13:50:37","date_gmt":"2024-03-29T20:50:37","guid":{"rendered":"https:\/\/lapost.us\/?p=63707"},"modified":"2024-03-29T13:50:37","modified_gmt":"2024-03-29T20:50:37","slug":"cdph-expands-california-prenatal-screening-program-panel-april-1","status":"publish","type":"post","link":"https:\/\/lapost.us\/?p=63707","title":{"rendered":"CDPH Expands California Prenatal Screening Program Panel April 1"},"content":{"rendered":"
\n

California will now screen for additional genetic conditions and birth defect<\/i><\/p>\n<\/div>\n

\n
\n\n\n\n
 <\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n

WHAT YOU NEED TO KNOW:\u00a0<\/strong>Beginning April 1, all pregnant women participating in the California Prenatal Screening Program will be screened for additional genetic conditions, allowing them greater access to more information on the health of their fetus.<\/p>\n<\/div>\n

\n
\n\n\n\n
 <\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n

SACRAMENTO<\/strong>\u00a0\u2013 The California Department of Public Health announced the expansion of the California Prenatal Screening (CA PNS) Program to include additional conditions on the screening panel beginning April 1. The statewide program is offered to all pregnant women in California to detect potential genetic conditions and birth defects in their developing fetus. California is the only state providing voluntary, standard-of-care prenatal screening to all individuals. Medi-Cal and private insurance generally cover all program fees and covered families do not have any out-of-pocket costs.<\/p>\n

\u201cAll pregnant women in California deserve access to the highest-quality prenatal screening and we\u2019re excited to be able to offer more information about the health of their pregnancy,\u201d\u00a0<\/em>said\u00a0CDPH Director and State Public Health Officer, Dr. Tom\u00e1s Arag\u00f3n<\/strong>.\u00a0\u201cWe are committed to working with our partners to ensure follow-up services are available at no additional cost to participants.\u201d<\/em><\/p>\n

The program currently screens for genetic conditions including Down syndrome, Trisomy 18 and 13, and neural tube defects, such as spina bifida. Due to patient demand and new\u00a0clinical practice guidelines<\/a>, beginning April 1, additions to the state cell-free DNA screening panel will include sex chromosome aneuploidies (SCAs) \u2013 also referred to as X and Y chromosome variations. These include:<\/p>\n